Generation Bio Co
GBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$35.98M
Close$
$-6.05
213.3% downside
Current Fair Value
213.3% downsideOvervalued by 213.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $35.98 Million |
|---|---|
| Enterprise Value | $40.29 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-19.76 |
| Beta | 2.01 |
| Outstanding Shares | 6,735,454 |
Return
| Return on Equity | -123.87% |
|---|---|
| Return on Assets | -51.38% |
| Return on Invested Capital | -63.99% |
Valuation & Multiples
| P/E Ratio | -0.57 |
|---|---|
| PEG | 0.9 |
| Price to Sales | 2.67 |
| Price to Book Ratio | 0.76 |
| Enterprise Value to Revenue | 2.64 |
| Enterprise Value to EBIT | -0.62 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.65 |
| Debt to Equity | 0.52 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 5, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 64.02%▲ 3.96% |
|---|---|
| Total Invested | $24.49M▲ 0.31% |
| Investors Holding | 45▲ 5.00% |
ESG Score
No data